
Prestige Consumer Healthcare Inc.
PBHHealthcare|Medical - Pharmaceuticals|US
$42.98
-1.34 (-3.02%)
DCF Value
$259.88
Graham Number
$54.85
Cash / Share
$0.98
Next Earnings Report
Feb 4, 2027
EPS est. $1.23 · Revenue est. $351.7M
Financing Filings (last 12 months)
0
No shelf registrations or offering prospectuses filed.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
Prestige Consumer Healthcare Inc. Reports Fiscal 2027 Second Quarter Results
Nov 5, 2026 · GlobeNewsWire
Amylyx Pharmaceuticals to Host Investor Event at ObesityWeek® 2026 Featuring Leading PBH Experts
Nov 4, 2026 · Business Wire
Prestige Consumer Healthcare to Release Fiscal 2027 Second Quarter Earnings Results
Oct 14, 2026 · GlobeNewsWire
More Than Half of U.S. Women Have Avoided Talking About an Intimate Wellness Concern Because They Felt Embarrassed or Uncomfortable, New Summer's Eve® Survey Finds
Sep 30, 2026 · PRNewsWire
Prestige Consumer Healthcare Inc. to Participate in Barclays Global Consumer Conference
Sep 8, 2026 · GlobeNewsWire
SEC Filings (38)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 5, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Nov 5, 2026 | 8-K | Material event | DocumentIndex |
| Aug 14, 2026 | 8-K | Material event | DocumentIndex |
| Aug 6, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 6, 2026 | 8-K | Material event | DocumentIndex |
| Jul 15, 2026 | 8-K | Material event | DocumentIndex |
| Jul 9, 2026 | 8-K/A | Material event | DocumentIndex |
| Jul 7, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jul 6, 2026 | 8-K | Material event | DocumentIndex |
| Jun 30, 2026 | 8-K/A | Material event | DocumentIndex |
| Jun 29, 2026 | ARS | Annual report to holders | DocumentIndex |
| Jun 29, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Jun 16, 2026 | 8-K | Material event | DocumentIndex |
| May 14, 2026 | 10-K | Annual report | DocumentIndex |
| May 13, 2026 | 8-K | Material event | DocumentIndex |
| Apr 30, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Apr 29, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Mar 27, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Mar 20, 2026 | 8-K | Material event | DocumentIndex |
| Feb 13, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 5, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Feb 5, 2026 | 8-K | Material event | DocumentIndex |
| Nov 14, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Nov 6, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Nov 6, 2025 | 8-K | Material event | DocumentIndex |
| Aug 13, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 7, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Aug 7, 2025 | 8-K | Material event | DocumentIndex |
| Jun 27, 2025 | ARS | Annual report to holders | DocumentIndex |
| Jun 27, 2025 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| May 9, 2025 | 10-K | Annual report | DocumentIndex |
| May 8, 2025 | 8-K | Material event | DocumentIndex |
| Apr 30, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 7, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 6, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Feb 6, 2025 | 8-K | Material event | DocumentIndex |
| Jan 23, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jan 6, 2025 | 8-K | Material event | DocumentIndex |